FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of benzoic acid of the formula (I): 
, wherein represents 0, 1 or 2; R1 represents halogen atom, (C1-C4)-alkyl group that is possibly substituted with one or more fluorine atoms, (C1-C4)-alkoxyl group that is possibly substituted with one or more fluorine atoms and when n represents 2 then substitutes at R1 can be similar or different; R2 represents direct (C2-C7)-alkyl group; R3 represents hydrogen atom (H) or -OCH3; W represents oxygen (O) or sulfur (S) atom, and to its pharmaceutically acceptable salts. Also, invention relates to a pharmaceutical composition used in treatment of hyperlipidemia, dyslipidemia, diabetes mellitus and obesity and comprising derivative of benzoic acid of the formula (I) in mixture with pharmaceutically acceptable adjuvants, excipients and/or carriers. Also, invention relates to using derivative of benzoic acid of the formula (I) for preparing a medicinal agent used in treatment of resistance to insulin. Also, invention relates to a method for synthesis of derivative of benzoic acid of the formula (I) and used for synthesis of intermediate compound of the formula (II) given in the invention description. Invention provides preparing derivatives of benzoic acid representing selective modulators of PPARα.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
8 cl, 14 ex
| Title |
Year |
Author |
Number |
| BENZOIC ACID DERIVATIVES AS PPAR α AND PPAR λ MODULATORS |
2003 |
|
RU2339613C2 |
| DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 |
2002 |
- Al'Stermark Lindstedt Ehva-Lotte
- Ol'Sson Anna Kristina
- Li Lanna
|
RU2303031C2 |
| DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTOR (PPARα) ACTIVATED BY PEROXISOME PROLIFERATORS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR DYSLIPIDEMIA TREATMENT AND TYPE 2 DIABETES MELLITUS |
2002 |
- Al'Stermark Lindstedt Ehva-Lotte
- Ol'Sson Anna Kristina
- Li Lanna
|
RU2300517C2 |
| 1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS |
2001 |
- Starke Ingemar
- Dal'Strom Mikaehl'
- Blomberg David
|
RU2302414C2 |
| BENZOTHIADIAZEPINE DERIVATIVES AND METHOD FOR PRODUCTION THEREOF (VARIANTS) |
2002 |
- Starke Ingemar
- Dal'Strum Mikaehl' Ul'F Jukhan
- Blumberg David
- Alenfal'K Suzanne
- Sharet Ture
- Lemurell' Malin
|
RU2305681C2 |
| USE OF IBAT INHIBITOR FOR TREATING AND PREVENTING CONSTIPATION |
2008 |
- Abrakhamsson Khasse Roland
- Gillberg Per-Goran
|
RU2482850C2 |
| BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS |
2020 |
- Gillberg, Per-Joran
- Mattson, Yan
- Starke, Ingemar
- Kulkarni, Santosh S.
|
RU2817535C2 |
| BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS |
2019 |
- Jillberg, Per-Jeran
- Mattsson, Yan
- Starke, Ingemar
- Kulkarni, Santosh S.
|
RU2785867C2 |
| IBAT ANTIOXIDANT APPLICATION FOR TREATMENT OR PREVENTION OF COPROSTASIA |
2004 |
- Abrakhamsson Khasse Roland
- Gillberg Per-Goran
|
RU2342928C2 |
| 1,4-BENZOTHIAZEPINE-1,1-DIOXIDE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD LIPID LEVEL, METHOD OF TREATMENT OF MAMMAL CLINICAL STATE, METHOD OF SYNTHESIS OF COMPOUND |
1995 |
|
RU2156245C2 |
